phase readout

NCT01804686: A Long-term Extension Study of PCI-32765 (Ibrutinib)

RECRUITINGupdated 13h ago

community read0 votes

Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B-cell Lymphoma, Waldenstrom Macroglobulinemia, Chronic Graft Versus Host Disease

view source ↗

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ctgov

last refreshed 55m ago

Found something off?